Table 1.
Modality | Contrast Agent (Examples) | Spatial Resolution (mm) | Advantages | Limitations | Clinical Application |
---|---|---|---|---|---|
CT | Iodine; nanoparticles; barium; krypton | 0.5–0.625 mm | Whole-body imaging available; high spatial resolution; short imaging time; unlimited depth penetration, inexpensive | Use of ionizing radiation; limited soft tissue contrast; molecular imaging not available; no real-time imaging | Yes |
US | Microbubbles | 0.04–0.1 (micro), 0.1–2 (clinical) | High sensitivity; non-ionizing radiation; real-time imaging; inexpensive, short acquisition time |
Whole-body imaging not possible; limited depth penetration; limited contrast agents | Yes |
Optical | Fluorescent dye; Nanoparticles |
1–5 mm | High sensitivity; non-ionizing radiation; real time imaging; inexpensive, short acquisition time |
Whole body imaging not possible; limited depth penetration; limited contrast agents | Yes |
MRI | Gadolinium; iron oxide nanoparticles; manganese nanoparticles | 0.01–0.1 (micro); 0.5–1.5 (clinical) | Non ionizing radiation; high spatial resolution; high soft tissue contrast; whole-body imaging possible; unlimited depth penetration |
Expensive imaging; long acquisition time; low sensitivity | Yes |
PET | Radioisotopes | 1–2 (micro); 5–10 (clinical) | High sensitivity; whole-body imaging possible; unlimited depth penetration; quantitative imaging; can combine with other imaging technologies and therapy | Expensive imaging; low spatial resolution; long acquisition time; ionizing radiation exposure; need cyclotron or nuclear reactor | Yes |
SPECT | Radioisotopes | 0.5–2 (micro); 6–15 (clinical) | High sensitivity; whole-body imaging possible; unlimited depth penetration; quantitative imaging; can combine with other imaging technologies and therapy | Expensive imaging; low spatial resolution; long acquisition time; ionizing radiation exposure; need cyclotron or nuclear reactor | Yes |